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Abstract 
Objective: In recent years there has been an increase in clinical situations requiring lead extraction procedures of 
implanted cardiac devices. In our clinic, extraction procedures are performed with Evolution® mechanical lead extrac-
tion system. In this manuscript we aimed to evaluate our lead extraction procedures.
Methods: We retrospectively evaluated lead extraction procedures carried out on 41 patients [30 male, 11 female 
patient; mean age 61.5 ± 18.5 median 67 (23–85)] between 2008 and 2015 using Evolution® system. Procedural suc-
cess, major and minor complications are determined according to previously published guidelines.
Results: Mean duration of the lead implantation was 88.4 ± 62.5 months (6–240). Implanted device was a pace-
maker in 27 (65.8 %) and ICD in 14 (34.2 %) of patients. Total 67 leads were extracted from the patients, 22 (32.8 %) 
were atrial, 30 (44.2 %) were ventricular, 14 (21.5 %) were dual coil defibrillator and 1 (1.5 %) was coronary sinus lead. 
Indications for lead removal were pacemaker decubitis and infection in 29 (70.8 %), lead dysfunction in 11 (26.8 %) 
and subclavian vein thrombosis in 1 (2.4 %) patient. Success rate with Evolution® system without using snare was 
85.3 %. Clinical success rate was 97.5 % procedural success rate was 95.1 % and failure occured in one patient. Major 
complications occured in 2 (4.8 %) patients, 1 (2.4 %) was procedure related mortality. Minor complications were seen 
in 5 (12.2 %) of patients.
Conclusions: In our single center study it is shown that extraction of pacemaker and defibrillator leads of relatively 
long implantation duration and in an older age patient group may be successfully carried out using the Evolution® 
system. However due to potentially serious complications it is adviced to be done by experienced operators in cent-
ers with cardiovascular surgery backup.
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Background
Indications of cardiac pacemaker and internal cardio-
verter defibrillators for management of cardiac arrhyth-
mias and heart failure have been broadening in past 
decades and there has been an increase in patients with 
cardiac devices. Clinical problems related with implanted 
cardiac device and leads such as pacemaker infections, 
decubitis ulcers, subclavian venous thrombosis, chronic 
pain at implantation site necessitating device and lead 
removal also increased dramatically (Wilkoff et  al. 
2009). Leads that are implanted less than 1 year may be 
explanted by simple traction but as implantation dura-
tion increases, formation of fibrous capsule around the 
lead makes extraction procedures difficult and neces-
sitates special devices for lead removal (Esposito et  al. 
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2002) Mechanical extraction systems, laser and radiofre-
quency devices and auxiliary appereils are needed to get 
rid of fibrous capsule adhesions around the lead and vas-
cular endothelium (Love 2007; Verma and Wilkoff 2004) 
In patients when all these methods fail, removal of leads 
may require open cardiac surgery.
Mechanical lead extraction systems are very useful 
tools developed for lead extraction procedures. They con-
sist of specially designed locking stylets which fix the lead 
and a hand-powered flexible dilator plastic sheath. The 
sheath has threaded metal distal tip which cuts fibrous 
adhesions when rotated by a handle. Unlike powered 
sheaths like laser or electrosurgical dissection sheaths, no 
energy form is used for extraction. The distal steel blade 
of the sheath can be more effective on calcified areas on 
which powered sheaths are less effective (Smith and Love 
2008). After the lead is fixed by locking stylet; the sheath 
is advanced over the lead-stylet complex to cut fibrotic 
adhesions and liberate the lead from vascular system. 
Evolution® mechanical dilator sheath which we use in 
our clinic for extraction procedures also has a telescopic 
outer polymer sheath which protects venous wall from 
the metal cutting tip. Leads are extracted by gentle trac-
tion, countertraction and by cutting through adhesions 
with this system. Mechanical extraction systems are less 
costly than laser systems and successful results are being 
reported with these systems recently (Starck et al. 2013; 
Mazzone et al. 2013).
In this manuscript we aimed to evaluate lead extrac-
tion procedures carried out in our clinic using Evolution® 
mechanical dilator sheath lead extraction system, com-
pared results with our preliminary experience and briefly 
reviewed literature on lead extraction systems.
Methods
41 Patients whose leads were extracted by Evolution® 
mechanical dilator sheath lead extraction system (Cook 
Medikal, Bloomington, IN, USA) in our clinic between 
2008 and 2015 were retrospectively evaluated. Patients 
whose leads were explanted by simple traction without 
using Evolution system are excluded from the trial. The 
procedures were performed by the same lead extraction 
team of operators who are experienced in implantation 
and revision of pacemaker and internal cardioverter defi-
brillators. The lead extraction procedures using Evolution 
system started in our clinic in 2008 with one patient and 
number of our patients increased since then. Between 
2009 and 2013 2, 3, 4, 4 and 6 procedures per year were 
done respectively. We published our preliminary experi-
ence in 2015 (Kocabas et al. 2015). When we doubled our 
total patient number to 41 by performing 8 procedures 
in 2014 and 13 in 2015 we decided to publish our con-
firmatory experience on lead extraction. Indications of 
lead extraction were determined based on Heart Rhythm 
Society 2009 Expert Consensus Statement on the Lead 
Extraction (Wilkoff et al. 2009). Informed consent forms 
were obtained from all patients before the procedure and 
local ethics committee approved our retrospective study.
Lead extraction technique
Lead extraction procedures were performed in cardiac 
catheterisation laboratory under local anesthesia and 
conscious sedation with non-invasive blood pressure 
monitorisation. Although most experts prefer to use 
invasive blood pressure monitorisation during the pro-
cedure due to technical difficulties in our laboratory we 
used non-invasive monitorisation. We increased the fre-
quency of blood pressure measurements at the critical 
stages of the procedure; during advancement of the sys-
tem at the subclavian vein and superior vena cava angle 
and while performing countertraction at the distal tip 
of implanted electrodes. There are successful reports of 
non-invasive monitorisaton during procedure (Oto et al. 
2011, 2012); but it is better to have invasive blood pres-
sure monitorisation when available. Temporary pacemak-
ers were implanted from femoral vein before procedure 
in pacemaker dependent patients. Pacemaker pocket 
region was explored using a sterile method and pace-
maker generator was explanted. The leads were explored 
and separated from surrounding fibrous tissues, sleeves 
and the capsule using blunt dissection while protecting 
lead’s lumen and integrity. After dissection of the lead 
from fibrous tissue up to subclavian vein puncture site; 
patency of lead’s lumen was checked by a standard stylet. 
If an active fixation lead was present, it was unscrewed 
from the endocardium. If the lead could not be explanted 
by gentle simple traction then special locking sytlet was 
exchanged with standard sytlet. This locking stylet was 
advanced towards the distal endocardial implantation 
site to fix the lead from the distal end. If the lumen’s 
integrity was damaged or locking stylets could not be 
advanced to the distal portion of the electrodes, a bulldog 
system was used for the fixation of lead in 11 (26.8 %) of 
our patients. After the fixation of lead, mechanical dila-
tor sheath was advanced over lead and locking stylet 
complex. The distal blades of mechanical dilator sheath 
cuts the fibrotic adhesions around the lead and the outer 
polymer sheath protects vascular structures. Extremely 
adhered leads could be separated by using two dila-
tors and an example of such condition which occured in 
two of our patients is shown in Fig. 1. It was imperative 
to stay co-axial to the lead’s plane at all times for pro-
tecting lead’s integrity during procedure. When distal 
implantation site was reached, instead of dilator’s metal 
distal end, outer polymer sheath was advanced to per-
form countertraction. By countertraction the distal tip 
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of lead was liberated from endocardium without causing 
avulsion. Then lead was pulled back into outer polymer 
sheath without leaving any foreign material in vascular 
system. If any lead remnants remained in vascular spaces 
they are removed by using snares from femoral route. We 
used 2 types of snares Needle’s Eye Snare (Cook Vascu-
lar, Leechburg PA USA) in one patient and Multisnare 
(Multisnare, PFM, Köln, Germany) in four patients. In 
pacemaker dependent patients who have undergone lead 
extraction procedure because of infection, new battery 
and lead implantation was performed at the contralateral 
site after having negative blood cultures for 72 h; which 
were obtained in 24  h of lead extraction procedure. In 
other patients the new battery and leads were implanted 
at the same or another session at the contralateral site. 
After the procedure cardiac rhythm, hemodynamic sta-
tus of patient were monitored closely in the intensive 
care unit regarding development of bleeding complica-
tions, pericardial tamponade, arrythmia problems. A lead 
extracted in our hospital is shown in Fig. 2.
Procedural success
Procedural success was defined as extraction of all leads 
and its components without causing any major complica-
tion. Clinical success is defined as extraction of all lead’s 
components or retention of a small component (<4 cm) 
that is not expected to cause a clinical problem in the 
long term. Major and minor complications are defined 
according to previously published guidelines.
Statistical analysis
Statistical analysis were performed using SPSS 12.0 pro-
gram. Continuous variables are expressed as mean ± SD, 
medians and categorical variables are defined as 
percentages.
Results
41 Patients whose leads were extracted by Evolution® 
mechanical dilator sheath lead extraction system in our 
clinic between 2008 and 2015 were included in our study. 
The clinical characteristics, concomitant diseases and 
types of implanted devices are summarised in Table  1. 
Fig. 1 Combined use of two mechanical dilator sheaths for separa-
tion of extremely adhered leads Fig. 2 The extracted lead
Table 1 Baseline characteristics of the study population
Age, mean ± SD 61.5 ± 18.5 median 67 (23–85)
Gender, n (%) 30 Male (73.2 %) 11 female (26.8 %)
Indication of initial device implantation, n (%)
 Sick sinus syndrome 16 (39 %)
 Complete AV block 11 (26.8 %)
 Ventricular arrhythmias, heart 
failure
14 (34.2 %)
Implanted device, n (%)
 Single chamber PM,VVI/VDD 7 (17 %), 6 (14.8 %)
 Dual chamber PM 14 (34 %)
 Single chamber ICD 6 (14.8 %)
 Dual chamber ICD 7 (17 %)
 Biventricular ICD 1 (2.4 %)
Prevalence of diseases, n (%)
 Heart failure 12 (29.2 %)
 Coronary artery disease 13 (31.7 %)
 Valvular disease 2 (4.8 %)
 Hypertension 19 (46.3 %)
 Diabetes 7 (17 %)
 Congenital heart disease 3 (7.2 %)
 Chronic obstructive lung disease 2 (4.8 %)
 Chronic renal failure 2 (4.8 %)
 Hypertrophic cardiomyopathy 1 (2.4 %)
 Arrythmogenic right ventricular 
disease
1 (2.4 %)
 Cirrohis of liver 1 (2.4 %)
 Brugada syndrome 1 (2.4 %)
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The devices implanted to the patients and lead extraction 
procedure details are presented in Table 2. Results of the 
procedures and complications are presented in Table 3.
Mean age of patients included in the study was 
61.5  ±  18.5 median 67 (23–85) (Table  1). Mean dura-
tion of lead implantation were 88 ± 62.5 months, median 
84  months (6–240) (Table  2). Devices were mostly 
implanted for sick sinus syndrome (39  %) followed by 
ventricular arrhythmias, heart failure (34.2 %) and com-
plete atrioventricular block (26.8 %) (Table 1). Implanted 
devices were pacemakers (PM) (65.8 %) and internal car-
dioverter defibrillators (ICD) (34.2 %) (Table 2). Extracted 
leads were 44.2  % ventricular, 32.8  % atrial, 21.5  % dual 
coil defibrillation leads and one coronary sinus lead was 
present. Majority of the leads (83.6 %) had passive fixa-
tion mechanism (Table  2). In one cardiac resynchroni-
sation defibrillator device (CRT-D) patient there was an 
additional nonfunctional atrial lead and in three patients 
there was one additional nonfunctional ventricular lead. 
These leads contribute to the total number of 67 leads in 
41 patients. Main reason for lead extraction was device 
infection and decubitis (70.8 %) (Table 2).
Success rate with Evolution system only was 85.3 % and 
snare was used to complete the procedure in 12.2  % of 
patients. Procedural success was 95.1 %, clinical success 
was 97.5 % and failure occured in one patient (Table 3). 
Major complication rate was 4.8 %, one case of mortality 
and one thoracotomy requirement due to right ventricu-
lar rupture caused by temporary pacemaker electrode 
(Table  3). Our minor complication rate is 12.2  % and 
these were vascular repair operation in 2 patients, pace-
maker pocket hematoma requiring surgery in 1 patient 
and pleural effusion in 1 patient and pericardial effusions 
in 1 patient (Table 3). Snare was used to remove retained 
lead components in 12.2  % of patients (Table  3). In 10 
(24.4 %) of patients indication for new device implanta-
tion was not present according to the 48 h Holter record-
ings and 5 patients declined new device implantation so 
we implanted a new device to 61.1  % of total patients 
(Table 3). All patients who did not have indication for a 
new device were patients diagnosed with sick sinus syn-
drome previously.
Discussion
In this single center study we demonstrated that in 
a patient group of advanced age and long implanta-
tion duration; pacemaker and defibrillator leads can be 
extracted using mechanical dilator sheath extraction 
system with acceptable success rates. In the literature 
various lead extraction methods including mechanical 
sheaths (polymer, steel), extraction devices (special lock-
ing stylet, snare), telescopic sheaths, mechanical extrac-
tion systems, laser and radiofrequency devices have been 
reported. In PLEXES study, where laser and other types 
of lead extraction systems (locking stylet, telescopic 
sheath) were used, procedural success rate were found to 
be 94 and 64 % for laser and other types of lead extraction 
systems respectively. Major complication rate was 1.96 % 
in laser group (Wilkoff et  al. 1999). In LexIcon study 
laser based system had procedural success rate 96.5  % 
and incidence of major adverse events was 1.4 % (Wazni 
et al. 2010). Although laser based systems seem to have 
Table 2 Procedure and implanted device characteristics
Implanted device, n (%) Pacemaker 27 (65.8 %) ICD 14 
(34.2 %)
Mean duration after initial implan-
tation
88.4 ± 62.5 months median 84 
(6–240 months)
Cardiac leads per patient, total n 
(%)
67
 One lead 17 (41.4 %)
 Two leads 23(56.2 %)
 Four leads 1 (2.4 %)
Lead type, n (%) 67
 Atrial 22 (32.8 %)
 Ventricular 30 (44.2 %)
 Defibrillation coil 14 (21.5 %)
 Coronary sinus lead 1 (1.5 %)
Fixation mechanism, n (%)
 Active fixation 11 (16.4 %)
 Passive fixation 56 (83.6 %)
Indication for removal, n (%)
 PM pocket dekubitis, infection 29 (70.8 %)
 Lead dysfunction 11 (26.8 %)
 Subclavian vein thrombosis 1 (2.4 %)
Table 3 Procedure and procedure related complications
Clinical success, n (%) 40 (97.5 %)
Procedural success, n (%) 39 (95.1 %)
Success rate without snare use, n (%) 35 (85.3 %)
Major complications 2 (4.8 %)
Mortality after procedure 1 (2.4 %)
Right ventricular rupture caused by temporary transvenous 
pacemaker
1 (2.4 %)
Cardiovascular surgery due to failure of procedure 1 (2.4 %)
Minor complications 5 (12.2 %)
Vascular repair operation by vascular surgeons 2 (4.8 %)
Pacemaker pocket hematoma requiring surgery 1 (2.4 %)
Pericardial effusion 1 (2.4 %)
Pleural effusion not requiring drainage 1 (2.4 %)
Snare need for lead or its components 5 (12.2 %)
Device implantation indication after procedure 31 (75.6 %)
Patients with device implantation after procedure 25 (61.1 %)
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a higher procedural success rate, its procurement is very 
difficult and it is quite costly. Besides it is not available in 
our country due to social security system reimbursement 
policy. Also these trials compared laser system with lock-
ing stylets and telescopic sheaths rather than the Evolu-
tion® system.
Procedural success rate of lead extraction with Evo-
lution® has been reported as 86  % by Hussein et  al. 
(2010). Oto et  al. (2011, 2012) reported their proce-
dural success rates 82 and 87.9  % in their first and sec-
ond reports respectively. Their clinical success rate was 
98.5  % in second report in a patient group with mean 
age 55.6  ±  11.5  years and median duration of implant 
85  months (22–240). Recently published studies indi-
cate that mechanical lead extraction systems can be as 
safe as laser systems and may be more cost effective. In 
a study performed by Mazzone et  al. (2013), no differ-
ence between laser and mechanical lead extraction system 
(Evolution®) was found with respect to procedural suc-
cess (97.3 vs. 91.7  % p =  0.16), clinical success (98.6 vs. 
97.9 % p = 0.76), major (2.7 vs. 4.2 %) and minor (5.5 vs. 
2.7 %)complication rates. In mechanical extraction system 
group more frequent need for snaring lead components 
is observed (8.2 vs. 27.1 %). However Evolution group in 
this study had higher number of leads per patient (2.77 vs. 
2.4 % p = 0.049) and longer implantation duration (101.1 
vs. 62.4 months p = 0.01). In another study which com-
pared both methods in patients who have longer implanta-
tion duration of mean 69.6 months, laser and mechanical 
extraction systems did not show any difference in proce-
dural success rates (76.9 vs. 88.6 % vs p =  0.132). Clini-
cal success rate (76.9 vs. 97 % p = 0.018) was better in the 
Evolution® group (Starck et al. 2013). Evolution® system 
was found superior to laser system regarding clinical suc-
cess and cost effectiveness. Mechanical extraction systems 
are also developing their technology with innovations 
like short handle system for better control of the sheath 
and different axis rotating blade for preventing wrapping 
of the leads during extraction procedures and these fea-
tures may result in better procedural success rates. Spec-
tranetics® which owns laser based extraction system on 
the other hand developed a Tightrail™ mechanical dila-
tor sheath system which is another mechanical extraction 
device similar to Evolution system. Tightrail™ sheath pro-
vides more flexibility compared to Evolution sheath and 
it has cutting blades inside the sheath unlike Evolution 
system. This feature may add safety during the extraction 
procedure. The preliminary clinical success rate of 95.7 % 
was reported by Aytemir et al. (2015) with this system. In 
the long term these outcomes may indicate a trend favor-
ing mechanical systems rather than laser system. The 
clinical characteristics and success rates of lead extraction 
procedures using mechanical extraction devices reported 
in literature and our  center’s results are summarised in 
Table 4 
Although we can successfully remove leads with 
mechanical dilator sheath extraction systems, procedure 
has serious life threatening complications. The Evolution 
is a big bulky device and has to be used by at least two 
experienced operators one holding the lead and stylet 
complex and other one cutting fibrotic attachments and 
advancing the dilator sheath. If their manipulations are 
not optimally coordinated the lead’s integrity can be eas-
ily damaged and heart and great vessels may be injured 
during the procedure. Major complications with percu-
taneous lead extraction procedures are cardiac rupture 
(1–4 %), emergency cardiac surgery requirement (1–2 %) 
and death (0.4–0.8  %) (Henrikson and Brinker 2008). In 
our experience we had 4.8 % major and 12.2 % minor com-
plication rates. These rates may be due to our relatively 
early experience, older age of patients and long implanta-
tion duration in our study. Compared to our preliminary 
results (Kocabas et al. 2015) clinical and procedural suc-
cess rates are similar but, our minor complication rates 
declined and less snare use is needed with more experi-
ence with the extraction system. Learning curve mostly 
occurs during first 10–20 cases and when compared with 
our previous report need for snares 20 % and other minor 
complications 25 % decreased to 12.2 %. Only one addi-
tional case of snaring was required in our second half 
of experience and other minor complications which we 
reported in preliminary results did not occur. Snaring was 
needed mostly in patients who have passive fixation elec-
trodes and previously damaged leads. However there was 
one case of mortality in our series. That patient suffered 
sudden cardiac arrest with electromechanical dissociation 
without any pericardial or pleural effusion, arrythmia or 
profound hypotension in intensive care unit 4 h after suc-
cessful procedure. He did not respond to iv fluids vaso-
pressors and cardiopulmoner resuscitation and expired 
before being taken into the cardiovascular surgery room. 
Autopsy was not performed but tear and late rupture of 
great vessels is suspected because two mechanical dilator 
sheaths (11F and 13F) were used in this patient to com-
plete the extraction procedure. Experience of the opera-
tor is important in preventing complications with these 
extraction systems; (Smith and Love 2008) and procedure 
must be performed at high volume cardiovascular centers 
with emergency cardiovascular surgery backup.
Conclusions
In our experience mechanical extraction systems appears 
to be the firstly preferred method in the extraction of 
leads in the long run. As number of cases performed 
using these systems increase their safety, effectiveness 
and complication rates will be understood more in detail.
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Husseina et al. 
(2010)
29 65 ± 19 65 (12–409) 100 86 0 0
Otoa et al. (2011) 23 58 ± 14 74 (25–180) 100 82 0 4.3
Otoa et al. (2012) 66 55 ± 11 85 (22–240) 98.5 87.9 1.5 3
Mazzonea et al. 
(2013)
48 65 ± 14 101 ± 66.4 97.9 91.7 4.2 2.7
Starcka et al. 
(2013)
122 60.4 69.6 (1–384) 97 88.9 2 3
Kocabasa et al. 
(2015)
20 61 ± 19 97 (8–204) 95 95 5 25
Aytemirb et al. 
(2015)
23 59 ± 13 72 (8–216) 100 95.7 0 0
This studya 41 61 ± 18 88 (6–240) 97.5 95.1 4.8 12.2
